HIGHLIGHTS
- who: Robert H. Eibl and Markus Schneemann from the , Schaffhausen, Switzerland have published the article: Medulloblastoma: From TP53 Mutations to Molecular Classification and Liquid Biopsy, in the Journal: Biology 2023, 12, x FOR PEER REVIEW of /2023/
- what: The aim of this review is to provide a timeframe of developments in medulloblastoma diagnostics and treatment, as well as to apply the combination of molecular diagnostics with liquid biopsy in the clinical management of medulloblastoma patients.
- future: Rorke challenged the theoretical debates in favor of focusing more on a practical approach to develop better . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.